Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer
Authors:
- Jay D. PearsonJPJay D. Pearson
- Jonathan I. EpsteinJEJonathan I. Epstein
- Patrick C. WalshPWPatrick C. Walsh
- H. Ballentine CarterHCH. Ballentine Carter
Open Access
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pitfalls in Interpreting Prostate Specific Antigen VelocityJournal of Urology, 1996
- Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocityUrology, 1995
- 5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate CancerJournal of Urology, 1994
- Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesUrology, 1994
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- Relationship between changes in prostate-specific antigen and prognosis of prostate cancerUrology, 1993
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate CancerJournal of Urology, 1993
- Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign HyperplasiaJournal of Urology, 1990